Molecular pathways linking the gut microbiome to antitumor immunity.

Gut microbiome-derived metabolites influence key molecular pathways that enhance antitumor immunity, with specific metabolites affecting immune responses and therapy efficacy.

• Why it matters: Understanding how gut bacteria modulate immune responses is crucial for improving cancer treatments, as current knowledge gaps hinder the development of microbiome-targeted therapies.
• What they did: The authors review existing research on bacterial species and their metabolites that impact antitumor immune activities, including epigenetic modifications and signaling pathways like cytokine production and toll-like receptor activation.
• The result: Identifying these metabolites and pathways offers potential for new therapeutic strategies and warrants further investigation in preclinical and clinical studies to optimize cancer immunotherapy.